• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Dr. G.H. Tichenor Antispetic Co. - Close Out Letter 12/27/13


Department of Health and Human Services' logoDepartment of Health and Human Services

 Food and Drug Administration
New Orleans District
404 BNA Drive
Building 200 – Suite 500
Nashville, TN 37217

Telephone: (615) 366-7801
            FAX: (615) 366-7802


December 27, 2013

R. Parker LeCorgne, President
Dr. G.H. Tichenor Antispetic Co.
4200 Poche Court West
New Orleans, LA 70129-2222

Dear Mr. LeCorgne:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter No. 2011-NOL-12, dated April 18, 2011. Based on our evaluation, it appears you have addressed the violations contained in this warning letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

If you have any questions, I may be reached at (615) 366-7988.




For: Ruth P. Dixon
Compliance Branch Director
New Orleans District